FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

FDA Tightening Research Use Only Tests: Lawyers

Three SheppardMullin attorneys say that manufacturers of tests labeled for research use only should review customer lists and promotional claims to be...

latest-news-card-1
Human Drugs

Fresenius Recalls Stay-Safe Catheter Sets

Fresenius Medical Care recalls its Stay-Safe Catheter Extension Sets and Stay-Safe/Luer Lock Adapters to correct their instructions for use to prevent...

latest-news-card-1
Human Drugs

Cancer Trial Performance Status Eligibility Criteria

FDA publishes a draft guidance on using patient performance status as eligibility criteria for cancer drug trials.

latest-news-card-1
Human Drugs

Laboratory Values Cancer Trial Eligibility Criteria

FDA publishes a draft guidance with recommendations for increasing cancer drug trial participant diversity by selecting appropriate laboratory values ...

latest-news-card-1
Medical Devices

Cardinal Health Monoject Inspection Violations

FDA warns Cardinal Health it is distributing unapproved medical devices that also have a Quality System Regulation violation.

latest-news-card-1
Human Drugs

Amneal Generic OTC Narcan Spray OKd

FDA approves an Amneal Pharmaceuticals ANDA for a generic over-the-counter naloxone hydrochloride nasal spray, 4mg, (generic Narcan) for treating a dr...

latest-news-card-1
Human Drugs

Cut Ozempic/Wegovy Price: HELP Committee

Sen. Bernie Sanders and the HELP Committee call on Novo Nordisk to significantly reduce the cost of its Ozempic and Wegovy in the U.S.

latest-news-card-1
Medical Devices

Curio Postpartum Depression Device Cleared

FDA clears a Curio Digital Therapeutics 510(k) for its MamaLift Plus, a prescription digital therapeutic for treating postpartum depression.

latest-news-card-1
Human Drugs

Zydus Lifesciences Issued Another FDA-483

An FDA inspection at Zydus Lifesciences injectable manufacturing site in Jarod, India results in a 10-observation Form FDA-483, the second received by...

latest-news-card-1
Human Drugs

Dr. Reddys Recalls Sapropterin Dihydrochloride

Dr. Reddys Laboratories recalls six lots of sapropterin dihydrochloride powder for oral solution 100 mg due to decreased potency.